Local recurrence is an important prognostic factor of hepatocellular carcinoma

Table 2 Comparison of clinical backgrounds between local recurrence group and local recurrence-free group

	Local recurrence
	(+)	(-)
n	44	96
Albumin (g/dL)	3.47 ± 0.49	3.60 ± 0.40
Bilirubin (mg/dL)	1.15 ± 0.53	1.20 ± 1.15
Platelets (104/L)	10.01 ± 9.89	9.62 ± 4.37
ALT (U/L)	85.16 ± 41.76	84.31 ± 49.50
HPT (%)	62.28 ± 18.64	60.35 ± 16.44
ICG-R15 (%)	29.04 ± 15.23	27.72 ± 15.39
AFP (ng/mL)	153.83 ± 539.31	63.24 ± 118.58
Tumor size (mm)	24.00 ± 9.48	18.92 ± 7.15d
Tumor number	1.77 ± 0.94	1.39 ± 0.69b
TACE prior to PEIT	22 (50%)	59 (61%)

^bP<0.01 vs local recurrence (+);

^dP<0.001 vs local recurrence (+).